THUNDER BAY, Ontario--(BUSINESS WIRE)--IGY Life Sciences today announced it will be collaborating with clinical data and regulatory experts, MMS Holdings (MMS), to further the development of IgY-110, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results